Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 AUD | -4.00% | +9.09% | +9.09% |
05:53am | IDT Australia Says Talks Continue Over Myndbio's Takeover Proposal | MT |
Jun. 04 | IDT Australia Raising About AU$7 Million Via Entitlement Offer; Shares Up 10% | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Active Pharmaceutical Ingredients and Finished Dose Forms
100.0
%
| 12 | 100.0 % | 7 | 100.0 % | -42.71% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 12 | 100.0 % | 7 | 100.0 % | -42.71% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul McDonald
CEO | Chief Executive Officer | - | 20-12-31 |
Director of Finance/CFO | - | 22-09-27 | |
Kagiaros Chris
HRO | Human Resources Officer | - | 21-08-31 |
Phil Wykes
PRN | Corporate Officer/Principal | - | - |
Mark Licciardo
SEC | Corporate Secretary | 60 | 22-10-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Simari
CHM | Chairman | 54 | 22-10-09 |
Geoffrey Sam
BRD | Director/Board Member | - | 22-10-09 |
Jane Ryan
BRD | Director/Board Member | 65 | 22-01-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 429,586,018 | 377,507,991 ( 87.88 %) | 0 | 87.88 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+9.09% | 29.02M | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 23.64B | |
+2.07% | 22.39B | |
-10.79% | 17.78B | |
-41.74% | 16.43B | |
-13.47% | 16.34B | |
+2.23% | 13.56B | |
+27.13% | 11.59B |
- Stock Market
- Equities
- IDT Stock
- Company IDT Australia Limited